Shattuck Labs (STTK) Current Assets (2019 - 2026)
Shattuck Labs' (STTK) quarterly Current Assets came in at $93.8 million in Q1 2026, up 41.19% year-on-year from $66.4 million in Q1 2025, and up 13.67% on a QoQ basis from $82.5 million in Q4 2025.
Shattuck Labs (STTK) Current Assets (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Current Assets data on file, last reported at $93.8 million in Q1 2026.
- On a quarterly basis, Current Assets rose 41.19% year-over-year to $93.8 million in Q1 2026; TTM through Mar 2026 was $93.8 million, a 41.19% increase from a year earlier, with the FY2025 full-year figure at $82.5 million, up 4.12% from the prior year.
- Current Assets for Q1 2026 stood at $93.8 million, up from $82.5 million in the prior quarter.
- Over the last five years, Current Assets for STTK reached as high as $255.0 million in Q1 2022 and fell as low as $54.7 million in Q2 2025.
- Historically, Current Assets has averaged $131.3 million across 5 years, with a median of $114.4 million in 2024.
- Across the five-year window, Current Assets tumbled 52.22% in 2025 and surged 41.19% in 2026, its largest moves.
- Year by year, Current Assets stood at $184.6 million in 2022, then declined by 22.41% to $143.2 million in 2023, then plunged by 44.69% to $79.2 million in 2024, then increased by 4.12% to $82.5 million in 2025, then gained by 13.67% to $93.8 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $93.8 million in Q1 2026, $82.5 million in Q4 2025, and $90.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 73.04 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 3.59 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 6.60 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.97 Bn |
| 10 | Shattuck Labs | 831.66 Mn | 831.66 Mn | - | 93.75 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 93.75 Mn |
| Dec 31, 2025 | 82.48 Mn |
| Sep 30, 2025 | 90.72 Mn |
| Jun 30, 2025 | 54.68 Mn |
| Mar 31, 2025 | 66.40 Mn |
| Dec 31, 2024 | 79.22 Mn |
| Sep 30, 2024 | 98.74 Mn |
| Jun 30, 2024 | 114.43 Mn |
| Mar 31, 2024 | 131.08 Mn |
| Dec 31, 2023 | 143.22 Mn |
| Sep 30, 2023 | 112.99 Mn |
| Jun 30, 2023 | 136.45 Mn |
| Mar 31, 2023 | 157.84 Mn |
| Dec 31, 2022 | 184.58 Mn |
| Sep 30, 2022 | 201.52 Mn |
| Jun 30, 2022 | 229.42 Mn |
| Mar 31, 2022 | 254.99 Mn |
| Dec 31, 2021 | 288.27 Mn |
| Sep 30, 2021 | 301.64 Mn |
| Jun 30, 2021 | 315.88 Mn |